Sai Life Sciences
SAILIFE · Pharma > Pharmaceuticals & Drugs Listing date: Dec. 18, 2024

Stock Price vs Company Growth
1d
0.6%
1w
5.0%
1m
12.7%
3m
8.4%
6m
45.8%
1y
60.5%
all
38.7%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,397 0.6%
1,217
1,687
Company Overview

Sales
2,250 Cr
Growth: 18.0%
Profit after Tax
361 Cr
Growth: 3.7%
Mid Cap
29,687 Cr
P/E: 82.5x
Industry P/E: 32.5x
Fundamentals

Sales (Cr) ₹ 2,250
Growth 18.0%
EBITDA 29.3%
P/S 13.2x
Dividend 0.0%
P/E 82.5x
Book Value ₹ 120
PEG Ratio 4.6x
ROE 14.9%
P/B 11.5x
Shareholding Pattern

Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed

The company is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization. It provides end-to-end services across the drug discovery, development and manufacturing value chain for small molecule new chemical entities to global pharmaceutical innovators companies and biotechnology firms. Awards, accreditations and recognitions2020: Awarded the ‘Risk Mitigation Award’ by Institute of Supply Chain Management Pvt. Ltd.
Followers (1)